News Press Contact: Kirsten Mabry | (617) 495-4157

Researchers in Andrew Kruse’s lab overcame a key obstacle in using the hormone relaxin as a therapy for heart disease. With support from Harvard’s Blavatnik Biomedical Accelerator, this discovery led to the launch of Tectonic Therapeutic, which is now testing its relaxin-based drug in clinical trials.

Researchers in the lab of Katia Bertoldi, the William and Ami Kuan Danoff Professor of Applied Mechanics at SEAS, published a study reporting that squeaking emerges from a previously unseen mechanism. Answering the question ‘why do gym sneakers squeak’ could lead to new ways to engineer and control tunable frictional metamaterials.

Drawing inspiration from how organisms regulate temperature using liquids—such as perspiration and blood vessel constriction—researchers at SEAS are developing a liquid-based screen that adheres to windows and controls how much heat and light pass through.

BioMed X and Harvard launched a pilot initiative under BioMed X’s XBridge framework to support structured research collaborations between academic investigators and pharmaceutical industry scientists through sponsored research agreements.